Table 2.
Goal of modification | Peptide |
---|---|
Stomach | |
Increased Stability | PEG, d-amino acids, nanoparticles, SLN |
Small intestine | |
Increased Stability | Cyclization, PEG, lipidization, d-amino acids, polymer matrices, nanoparticles, esterification, N-acetylation |
Enzyme Inhibitors | Soybean trypsin inhibitor, aprotinin, puromycin, bacitracin |
Absorption Enhancers | Chitosans, fatty acids, lectins, ZOT, CPP, liposomes, nanoemulsions, mucoadhesive polymers, nanoparticles, SLN |
Circulation | |
Increased Stability | PEG, hyperglycosylation, liposomes, nanoparticles |
Targeting | Antibody CPP |
CPP: Cell-penetrating peptide; SLN: Solid lipid nanoparticle; ZOT: Zonula occludens toxin.